Stockreport

These 3 Stocks Trigger Bearish Signals but 2 Offer Hidden Opportunity [Yahoo! Finance]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF by 22.7% due to a $1.39B acquired IPRD charge, while legacy drugs Revlimid and Sprycel fell 55% and 60% respectively with generic pomalidomide entry expected in Q1 2026. [Read more]